Identification of an important potential confound in CSF AD studies: aliquot volume. by Toombs, Jamie et al.
Toombs, J; Paterson, RW; Lunn, MP; Nicholas, JM; Fox, NC; Chap-
man, MD; Schott, JM; Zetterberg, H (2013) Identification of an im-
portant potential confound in CSF AD studies: aliquot volume. Clin-
ical chemistry and laboratory medicine , 51 (12). pp. 2311-7. ISSN
1434-6621 DOI: 10.1515/cclm-2013-0293
Downloaded from: http://researchonline.lshtm.ac.uk/1462859/
DOI: 10.1515/cclm-2013-0293
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Copyright the author(s)
DOI 10.1515/cclm-2013-0293      Clin Chem Lab Med 2013; aop
 Jamie  Toombs* a ,  Ross W.  Paterson* a ,  Michael P.  Lunn ,  Jenifer M.  Nicholas ,  Nick C.  Fox ,  
Miles D.  Chapman ,  Jonathan M.  Schott and  Henrik  Zetterberg 
 Identification of an important potential confound 
in CSF AD studies: aliquot volume 
 Abstract 
 Background: Cerebrospinal fluid (CSF) amyloid beta 1-42 
(A β 1-42), total tau (T-tau) and phosphorylated tau181 
(P-tau) are finding increasing utility as biomarkers of 
Alzheimer ’ s disease (AD). The purpose of this study was 
to determine whether measured CSF biomarker concen-
trations were affected by aliquot storage volume and 
whether addition of detergent-containing buffer mitigates 
any observed effects. 
 Methods: AD and control CSF was distributed into 
polypropylene tubes in aliquots of different volumes 
(50 – 1500  μ L). A β 1-42, T-tau and P-tau were measured with 
and without addition of Tween 20 (0.05%). 
 Results: Measured concentrations of A β 1-42 increased 
two-fold with aliquot storage volume. A volume increase 
of 10  μ L caused an A β 1-42 increase of 0.95  pg/mL [95% 
confidence interval (CI) 0.36 – 1.50, p = 0.02] in controls, and 
0.60 pg/mL (CI 0.23 – 0.98 pg/mL, p = 0.003) in AD samples. 
Following addition of Tween 20, the positive relationship 
between A β 1-42 and aliquot volume disappeared. T-tau 
and P-tau were not significantly affected. 
 Conclusions: CSF aliquot storage volume has a signifi-
cant impact on the measured concentration of A β 1-42. 
The introduction of a buffer detergent at the initial 
aliquoting stage may be an effective solution to this 
problem. 
 Keywords:  Alzheimer ’ s disease;  amyloid  β ;  cerebrospinal 
fluid;  tau;  volume. 
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 Introduction 
 Cerebrospinal fluid (CSF) amyloid beta 1-42 (A β 1-42), total 
tau (T-tau) and phosphorylated tau181 (P-tau) can be used 
to help diagnose Alzheimer ’ s disease (AD) pathology in 
individuals with cognitive impairment [1]. These biomark-
ers are widely measured for clinical, research and drug 
development purposes. However there is considerable 
variability in collection procedures and laboratory han-
dling methods, leading to inconsistency in the apparent 
concentrations of these analytes between individuals and 
between different laboratories [2]. 
 Known confounding factors in the measurement of 
A β 1-42 and T-tau concentrations include delays in sample 
analysis [3], diurnal variation [4], CSF contamination with 
blood or breakdown of the blood brain barrier [5, 6] and 
choice of storage tube material [7]. Of the various ana-
lytes, A β 1-42 seems to be most influenced by such external 
factors, due at least in part to the hydrophobic nature of A β 
and its propensity to be adsorbed to the walls of collection 
containers, as well as to aggregate with itself and other 
proteins [5]. The use of polypropylene (PP) tubes mitigates 
the problem of adsorption to a large extent, but does not 
guarantee satisfactory pre-analytic behaviour as most PP 
tubes are made of copolymers to which A β adsorbs to dif-
ferent degrees depending on the tube manufacturer [7]. 
 We hypothesised that apparent A β 1-42, T-tau and 
P-tau concentrations could also be altered by varying 
the aliquot volume in which they are stored, and conjec-
tured that increasing the ratio of CSF volume to surface 
area of PP storage container would result in decreased 
analyte adsorption. Furthermore, we explored whether 
we could mitigate any such effects by pre-treating with 
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a buffer-containing detergent that would lead to reduced 
tube surface adsorption and more complete measurement 
of analyte concentrations. 
 Materials and methods 
 Sample pools 
 CSF aliquots of diff erent volumes, collected and stored in PP tubes at 
 − 80 ° C according to standardised operating procedures [1], were test-
ed for A β 1-42, T-tau, and P-tau. Experiments were conducted in fi ve 
rounds. In each round, two pools of CSF were used: the fi rst, from a 
cohort of de-identifi ed subjects with CSF biomarker profi les consist-
ent with AD. These were identifi ed according to cut-off s that, taken 
together, are 90% sensitive and specifi c for AD [8]: A β 1-42  < 530 ng/L, 
T-tau  > 350 ng/L, P-tau  > 60 ng/L. An exception had to be made for 
the AD pool used in Rounds 4 and 5 due to insuffi  cient quantities 
accessible. This pool was composed of CSF that met the criteria for 
A β 1-42 and T-tau, but not P-tau. The second pool was composed of 
de-identifi ed non-AD control (CTRL) CSF (all three biomarker concen-
trations within normal range). Pooled CSF was used due to the large 
CSF volume requirement of the study design. Diff erent CSF pools 
were used over the rounds: Round 1 was unique and contained only 
neat CSF, Rounds 2 and 3 were identical except for the addition of a 
detergent buff er [Tween 20 (0.05%)] to the CSF of Round 3. Rounds 
4 and 5 used identical pools, and included AD and control, neat and 
Tween, individual and pooled CSF types all in the same plate in order 
to verify comparability of results. 
 To confi rm that pooled CSF would behave in the same way as 
that of individual patients, a series of aliquots of diff ering volumes 
was created from the CSF of single subjects (IND) and tested along-
side the pooled samples. 
 Sample treatment 
 Pools were created from individual samples of CSF taken by lum-
bar puncture, which were poured into a PP 100  mL beaker. The 
CSF was mixed thoroughly for 30 min with a magnetic stirrer and 
then poured into a PP 50 mL falcon tube. This tube was centrifuged 
at 3000  g for 10 min. CSF from the centrifuge tube was then split 
into two equal halves, again using 50 mL falcons, and 0.05% tween 
was added to one. Samples were aliquoted into a range of volumes 
(50  μ L, 75  μ L, 100  μ L, 125  μ L, 250  μ L, 500  μ L, 1000  μ L, 1500  μ L) 
and frozen at  − 80 ° C. This process took 1.5 h. Every sample in this 
study was used on its second thaw, except the Round 2 individual 
subject pool which was used on its fi rst thaw. Round 1 samples 
were incubated at  − 80 ° C for 2 months before testing, whilst Rounds 
2 – 5 were incubated at  − 80 ° C for a week. All samples were stored in 
Sarstedt (N ü mbrecht, Germany), 2 mL PP, skirted, screw top tubes 
(cat. 72.694.406). 
 Aliquots used in the A β 1-42 and T-tau plates were thawed to-
gether at room temperature for approximately 1 h, and dispensed 
into disposable PP plates for dilution (1:8 and 1:2, respectively). P-tau 
aliquots were thawed by the same process, but not diluted. All solu-
tions were mixed by continuous vortexing for 5 s. 
 Schedule and CSF analysis 
 Each round of experiments was conducted separately, and run over 
2 days, with A β 1-42 and T-tau plates tested in parallel on the fi rst day. 
P-tau was commenced on the fi rst day, incubated overnight, and con-
cluded on the second. A β 1-42 and T-tau were assayed on a Meso Scale 
Discovery 6000 platform, using MSD Human A β 1-42 and MSD Human 
Total Tau kits, respectively (Meso Scale Discovery, Gaithersburg, MD, 
USA). P-tau was run with and INNOTEST  ®  PHOSPHO-TAU(181P) ELI-
SA kit (Innogenetics, Ghent, Belgium), and measured using a BMG 
Labtech FLUOstar Omega multi-mode microplate reader. In Rounds 
1, 2 and 3, samples from the AD and CTRL pools were run in triplicate 
on each plate, whilst those from Rounds 4 and 5 were run in dupli-
cate due to volume restrictions. The manufacturer ’ s protocol was fol-
lowed exactly for each assay, with the exception of vortex time in the 
P-tau assay where 5 s was preferred to 10 in the interest of plate set-up 
speed and consistency across all assays. 
 Statistical analysis 
 Linear regression was used to examine the relationship between 
analyte concentration values and sample volume. The median of the 
measured analyte concentration values was the dependent variable 
and sample volume was the independent variable of interest. Pooled 
samples were analysed separately and, to increase power, together 
over multiple rounds (Supplementary data, Table 1, which accompa-
nies the article at  http://www.degruyter.com/view/j/cclm.2013.51.is-
sue-12/issue-fi les/cclm.2013.51.issue-12.xml), incorporating Round as 
a covariate. Individual samples were used as a point of comparison, 
but not analysed statistically as each was only run in a single round. 
All analyses were conducted in Stata Version 12.1. Graphs were cre-
ated using SPSS version 21. 
 Surface area calculation 
 To calculate the relative surface area (SA) per volume in the storage 
tube used, measurements provided by the manufacturers (Sarstedt, 
N ü mbrecht, Germany) were used to calculate the internal surface ar-
eas at each volume. This was done by adding the lateral SA of a hol-
low cylinder to that of a cone. All calculations were made using the 
relevant calculators on  www.aqua-calc.com [9]. 
 Results 
 A β 1-42 
 For both control and AD CSF, combining Rounds 1, 2 and 
4 an approximately two-fold increase in measured neat 
A β 1-42 concentration was observed between the largest 
and smallest aliquot volumes ( Figure 1 A). In regression 
analysis, for controls, an increase of 10  μ L aliquot volume 
was associated with a significant increase in A β 1-42 
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concentration (0.95  pg/mL [95% confidence interval (CI) 
0.36 – 1.50, p = 0.02]. A similar, stronger effect was seen 
in AD CSF: 0.60  pg/mL (CI 0.23 – 0.98 pg/mL, p = 0.003). 
In Rounds 3, 4 and 5 ( Figure 1 B), 0.05% Tween 20 was 
added to all aliquots, following which there was no longer 
a significant relationship between aliquot volume and 
measured A β 1-42 concentration in either the control CSF 
(Supplementary data, Table 1). 
 T-tau 
 In Rounds 1, 2 and 4 ( Figure 2 A) there was no associa-
tion between measured T-tau concentration and aliquot 
volume for the control pools. An increase of 10  μ L 
aliquot volume was associated with a non-significant 
increase in control T-tau concentration of 0.17  pg/mL 
(CI  − 0.53 – 0.87 pg/mL, p = 0.06). For pooled AD samples 
an increase of 10  μ L aliquot volume was associated with 
a non-significant increase in measured concentration 
of 0.05  pg/mL (CI  − 1.78 – 1.88 pg/mL, p = 0.96). For the 
individual samples ( Figure 2 D) there was no significant 
association between volume and measured concentra-
tion in the individuals tested. The addition of Tween 20 
( Figure 2 B) made no difference to the relationship 
between T-tau and volume. 
 P-tau 
 The results for P-tau can be seen in  Figure 3 . In Rounds 1, 
2 and 4 ( Figure 3 A) there was no significant association 
between neat sample P-tau concentration and aliquot 
volume in AD CSF (0.03  pg/mL (CI  − 0.01 – 0.06 pg/mL, 
p = 0.10). In pooled control CSF samples (0.03  pg/mL (CI 
0.00 – 0.05 pg/mL, p = 0.03), the relationship was signifi-
cant when all three rounds were combined (Supplementary 
Data, Table 1). With the addition of Tween 20 ( Figure 3 B) 
the association between P-tau and volume disappeared. 
 Tube surface area 
 Figure 4 A shows the estimated surface area of each aliquot 
relative to volume, and compares this to the average results 
of A β 1-42 at each volume. The average values were calcu-
lated from the combined A β 1-42 data of relevant (i.e., neat 
or Tween) individual and pooled CSF from every round of 
experimentation. Lower volumes are associated with higher 
relative surface area and lower measured concentrations of 
A β 1-42. This is further demonstrated by a strong inverse 
correlation (R 2 = 0.912) between concentration of neat A β 1-
42 and relative surface area ( Figure 4 B). No correlation 
(R 2 = 0.024) was found in Tween A β 1-42 samples ( Figure 4 C). 
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 Figure 1   Shown are the results of A β 1-42 over five rounds. 
 (A) Results of neat pooled and individual CSF A β 1-42, Rounds 1 – 5, AD and control groups. Sample R1 neat CTRL #2 failed to react at 1000  μ L 
(signal below blank) and has been excluded. (B) Results of 0.05% Tween-treated pooled and individual CSF A β 1-42, Rounds 1 – 5, AD and 
control groups. 
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 Discussion 
 This study demonstrates that the storage volume of CSF 
samples has significant impact on the measured concen-
tration of A β 1-42. The introduction of a buffer detergent 
to CSF samples at the initial aliquoting stage may be an 
effective solution to this problem. T-tau and P-tau con-
centrations generally appeared stable. These findings are 
consistent with the hypothesis that the hydrophobic prop-
erties of A β 1-42 lead to adsorption of this protein to the 
walls of the storage vessel. In this section, we consider the 
impact of surface area, and other factors that may have 
influenced results. 
Total tau: Neat AD and CTRL CSF from all Rounds Total tau: Tween AD and CTRL CSF from all Rounds
1300 Sample Sample
1200
1100
1000
900
800
700
600
500
400
300
200
100
0
50 75 100 125 250 500 1000 1500
Volume, µL
50 75 100 125 250 500 1000 1500
Volume, µL
A B
A
na
ly
te
 c
on
ce
nt
ra
tio
n,
 p
g/
m
L
1300
1200
1100
1000
900
800
700
600
500
400
300
200
100
0
A
na
ly
te
 c
on
ce
nt
ra
tio
n,
 p
g/
m
L
R1 Neat AD #1
R1 Neat AD #2
R1 Neat AD #3
R1 Neat CTRL #1
R1 Neat CTRL #2
R1 Neat CTRL #3
R2 Neat AD #1
R2 Neat AD #2
R2 Neat AD #3
R2 Neat CTRL #1
R2 Neat CTRL #2
R2 Neat CTRL #3
R4 Neat AD #1
R4 Neat AD #2
R4 Neat CTRL #1
R4 Neat CTRL #2
R5 IND Neat AD #1
R5 IND Neat AD #2
R5 IND Neat CTRL #1
R5 IND Neat CTRL #2
R3 Tween AD #1
R3 Tween AD #2
R3 Tween AD #3
R3 Tween CTRL #1
R3 Tween CTRL #2
R3 Tween CTRL #3
R4 Tween AD #1
R4 Tween AD #2
R4 Tween CTRL #1
R4 Tween CTRL #2
R4 IND Tween CTRL #1
R4 IND Tween CTRL #2
R5 Tween AD #1
R5 Tween AD #2
R5 Tween CTRL #1
R5 Tween CTRL #2
R5 IND Tween AD #1
R5 IND Tween AD #2
 Figure 2   Shown are the results of T-tau over five rounds. 
 (A) Results of neat pooled and individual CSF Total tau, Rounds 1 – 5, AD and control groups. Samples R1 neat CTRL #2 and R4 neat AD #1 
failed to react at 1500  μ L and 500  μ L, respectively (signal below blank). These data points have been excluded. (B) Results of Tween-treated 
pooled and individual CSF Total tau, Rounds 1 – 5, AD and control groups. 
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 Figure 3   Shown are the results of P-tau over five rounds. 
 (A) Results of neat pooled and individual CSF Phospho-tau, Rounds 1 – 5, AD and control groups. (B): Results of Tween-treated pooled and 
individual CSF Phospho-tau, Rounds 1 – 5, AD and control groups. 
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 Surface area 
 There was an inverse relationship between the measured 
concentration of A β 1-42 and the surface area per volume 
ratio of storage tube tested ( Figure 4 ). This suggests that 
surface adsorption is a key factor in the observed tendency 
for A β 1-42 concentration to increase with storage volume. 
 In the pooled AD CSF of Round 1 there was an associa-
tion between volume and measured T-tau concentration, 
but this could not be reproduced in subsequent assays. 
The control and individual pools for T-tau consistently 
demonstrated no significant effect between volume and 
concentration, and this was also the case for all P-tau 
pools taken individually. However, when analysed in com-
bination the neat control P-tau pool did show significant 
concentration increase with volume, and therefore may 
Surface area as a percentage of volume for a starstedt storage tube, compared to
average concentrations of neat and Tween Aβ1-42 from all rounds
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 Figure 4   (A) Shown on the left y-axis are the calculated percentage values for surface area, relative to volume, for CSF in a 2 mL Sartstedt 
tube (72.694.406). Shown on the right y-axis are the average values, at each volume, for neat and Tween A β 1-42 combining individual and 
pooled CSF data from all rounds. (B) Correlation analysis of average values for neat A β 1-42 (combining individual and pooled CSF from all 
rounds) against surface area as a percentage of volume. Results show a strong trend for A β 1-42 concentration to decline with increased 
surface area. Full line = best fit. Dashed line = 95% confidence interval. (C) Correlation analysis of average values for neat A β 1-42 (combining 
individual and pooled CSF from all rounds) against surface area as a percentage of volume. Results show no correlation between A β 1-42 
concentration and surface area. Full line = best fit. Dashed line = 95% confidence interval. 
also be affected by surface area dependent adsorption. It 
must be noted that the relative increase is of much smaller 
magnitude than observed in A β 1-42 (expressed by the 
coefficient in Supplementary Data, Table 1) and is clini-
cally irrelevant. 
 The frequent deviation in the concentrations of all 
three biomarkers which were stored in a 1500  μ L volume 
is inexplicable and disturbing. It is difficult to ration-
alise this as an effect of volume in regard to surface 
area, especially as Tween 20 samples were also affected. 
Instead, it may be that when volume approximates a 
tube ’ s maximum capacity, the remaining space is insuf-
ficient to allow thorough mixing by the method of vor-
texing used. Given the magnitude of deviation across 
multiple samples, this tendency deserves to be explored 
further. 
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 Figure 4 shows that, although neat A β 1-42 concen-
tration and surface area are strongly correlated, they do 
not perfectly correspond. Additionally,  Figures 1 – 3 show 
that the magnitude of concentration increase (or stability 
in the case of the tau isoforms) was not always the same. 
Therefore it seems that whilst surface area appears to play 
a key role in the effect, other factors may be involved. 
 Tween 20 
 The effect of Tween 20 provides further evidence for the 
hypothesis that protein is lost due to surface adsorption or 
aggregation. Tween 20 A β 1-42 samples had considerably 
higher concentrations of A β 1-42 than the neat samples. 
This suggests that a greater proportion of A β 1-42 mol-
ecules were free in the solution of the storage tube, and 
is consistent with the findings of other studies [5, 10, 11]. 
If Tween 20 were to be added routinely to samples then 
A β 1-42 cut points for clinical practice and clinical trials 
would require to be adjusted accordingly. Tween 20 tau 
sample results very closely reflected the results of neat 
samples, suggesting negligible quantities of tau are lost to 
surface adsorption, and that Tween 20 does not appreci-
ably alter detection. This could suggest that the significant 
P-tau result may not be attributable to surface area derived 
adsorption. 
 Temperature 
 An alternative explanation of, or contributor to, the 
observed association between volume and concentration 
is the effect of differing thaw times. It is known that the 
number of freeze/thaw cycles have an effect on the protein 
concentration of a sample [3]. Every sample in this study 
was used on its second thaw or less. All aliquots were 
thawed together at room temperature for approximately 
1 h, but large volume samples thaw more slowly ( − 80 –
 approx. 21 ° C took approximately 60  min for a 1500  μ L 
aliquot) and so spent less time at room temperature than 
the low volume samples. It may be that the additional 
time spent at room temperature for lower volume samples 
allowed more proteins (particularly A β 1-42) to denature, 
become proteolysed, aggregate, or adhere. Kaiser et  al. 
have shown that measured A β 1-42 in CSF becomes ele-
vated over time at room temperature. In their experiment, 
average A β 1-42 concentration of samples frozen imme-
diately was 790.8 ± 329.2 pg/nL (CV = 41.6%) compared to 
848.5 ± 287.1 pg/nL (CV = 33.8%) in samples frozen after 24 h 
[12]. Tau species were not found to be significantly affected 
(T-tau = 304.3 ± 178.0 pg/nL versus 308.0 ± 169.2 pg/nL; 
P-tau = 59.4 ± 29.9 pg/nL) [13]. However, even in A β 1-42, 
difference was not significant after a period of 2 h (only 
becoming so after 24 h), and so unlikely to have affected 
our volume experiment. Additionally, the increase in 
concentration over time in Kaiser et al. ’ s study has been 
conjectured to be the result of cell lysis, as cells were not 
removed by centrifugation [5]. Bjerke et al. also reported 
no difference between thawing samples at room tempera-
ture,  + 4 ° C, and  + 20 ° C in a water bath [5]. However, to our 
knowledge no study has examined the impact of thawing 
different volumes, and it remains possible that this is a 
factor. 
 Further work 
 Greater adsorption of A β 1-42 to vessel wall in proportion 
with volume to surface ratio is both credible and compat-
ible with the results observed. The similar trend observed 
in the T-tau AD pool of Round 1, but not in other rounds, 
is not easily explained: this might suggest that T-tau is 
susceptible to differences in storage volume in certain 
circumstances (i.e., in pooling), but could also simply 
be a chance finding. Reflecting on the volume effect 
identified when P-tau rounds were combined, it is worth 
considering that the T-tau assay detects six isoforms of 
the protein, and it may be that some are more vulner-
able than others to the factors previously discussed. 
Further studies are required to examine the extent of this 
phenomenon. 
 Conclusions 
 A β 1-42, T-tau and P-tau are now widely used as diagnos-
tic markers for Alzheimer ’ s pathology. It is, therefore, 
concerning that a two-fold difference can exist between 
the measured A β 1-42 concentrations of the 50  μ L and 
1500  μ L volumes in both AD and control CSF. This could 
easily result in misclassification of individuals in both 
clinical and research settings, and is a source of vari-
ance that, to our knowledge, has not previously been 
considered or investigated. As we move towards  ‘ ana-
lytical harmonisation ’ of CSF between centres [13], we 
propose that aliquot volume should also be standard-
ised. Furthermore, as the addition of a readily available 
buffer detergent appears to neutralise the effect of A β 1-
42 adsorption (and potentially that of other biomarkers), 
the addition of Tween 20 to aliquots immediately before 
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sample storage should also be explored as a practical 
solution to the problem. 
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